Please use this identifier to cite or link to this item:
http://hdl.handle.net/1843/41299
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.creator | Ingrid Vasconcelos | pt_BR |
dc.creator | Pedro Henrique Reis da Silva | pt_BR |
dc.creator | Derick Rodrigues Davila Dias | pt_BR |
dc.creator | Maria Betânia de Freitas Marques | pt_BR |
dc.creator | Wagner da Nova Mussel | pt_BR |
dc.creator | Tércio Assunção Pedrosa | pt_BR |
dc.creator | Maria Elisa Scarpelli Ribeiro e Silva | pt_BR |
dc.creator | Roberto Fernando de Souza Freitas | pt_BR |
dc.creator | Ricardo Geraldo de Sousa | pt_BR |
dc.creator | Christian Fernandes | pt_BR |
dc.date.accessioned | 2022-05-02T20:11:44Z | - |
dc.date.available | 2022-05-02T20:11:44Z | - |
dc.date.issued | 2020-11 | - |
dc.citation.volume | 116 | pt_BR |
dc.citation.spage | 1 | pt_BR |
dc.citation.epage | 3 | pt_BR |
dc.identifier.doi | 10.1016/j.msec.2020.111191 | pt_BR |
dc.identifier.issn | 0928-4931 | pt_BR |
dc.identifier.uri | http://hdl.handle.net/1843/41299 | - |
dc.description.resumo | Gliclazide is a sulfonylurea frequently prescribed for the management of type 2 diabetes mellitus in elderly patients and for patients with chronic renal or hepatic diseases. Even though it is considered a safer alternative, the drug can provoke side effects in some patients, especially hypoglycemia, due to the high interindividual variability. Therefore, the quantification of gliclazide in biological samples is usually recommended in order to assure efficacy and safety of the pharmacotherapy. However, due to the complexity of biological matrices, therapeutic monitoring can be very challenging, especially in the sample preparation step. For that reason, the synthesis and characterization of a novel and selective molecularly imprinted polymer (MIP) was proposed to be employed as sorbent for the extraction of gliclazide from human plasma samples by a molecularly imprinted solid-phase extraction (MISPE) procedure. Synthesis conditions were optimized (monomer, crosslinker and porogen) and the polymer was characterized for its morphological, physicochemical and stability properties. The influence of drug concentration, solvent composition and pH on the coefficient of distribution (Kd) and imprinting factor (IF) were studied, as well as repeatability between batches and selectivity. A bioanalytical method was developed applying the developed MIP as sorbent in solid phase extraction and liquid chromatography using a Poroshell 120 C18 (100 × 4.6 mm, 4 μm) column, acetonitrile and 10 mM potassium phosphate buffer pH 3.0 (50:50) at a flow-rate of 1.2 mL/min as mobile phase, temperature of 30 °C, injection volume of 40 μL and detection at 230 nm. The best reaction yield, extraction capacity, and selectivity was obtained using 2-hydroxyethyl methacrylate (2-HEMA), ethyleneglycol dimethacrylate (EGDMA) and acetonitrile. The optimized MIP showed coefficient of distribution (Kd) of 59.85 μg/g, imprinting factor (IF) of 1.60, and selectivity for gliclazide and other sulfonylureas compared to possible concurrent drugs. The developed method by MISPE-HPLC-UV showed to be appropriate to determine gliclazide in human plasma samples. | pt_BR |
dc.description.sponsorship | CNPq - Conselho Nacional de Desenvolvimento Científico e Tecnológico | pt_BR |
dc.description.sponsorship | FAPEMIG - Fundação de Amparo à Pesquisa do Estado de Minas Gerais | pt_BR |
dc.description.sponsorship | CAPES - Coordenação de Aperfeiçoamento de Pessoal de Nível Superior | pt_BR |
dc.description.sponsorship | Outra Agência | pt_BR |
dc.format.mimetype | pt_BR | |
dc.language | eng | pt_BR |
dc.publisher | Universidade Federal de Minas Gerais | pt_BR |
dc.publisher.country | Brasil | pt_BR |
dc.publisher.department | FAR - DEPARTAMENTO DE ALIMENTOS | pt_BR |
dc.publisher.department | FAR - DEPARTAMENTO DE PRODUTOS FARMACÊUTICOS | pt_BR |
dc.publisher.initials | UFMG | pt_BR |
dc.relation.ispartof | Materials Science and Engineering: C | pt_BR |
dc.rights | Acesso Aberto | pt_BR |
dc.subject | Diabetes mellitus | pt_BR |
dc.subject | Sulphonylureas | pt_BR |
dc.subject | Molecularly imprinted solid-phase extraction | pt_BR |
dc.subject | Sample preparation | pt_BR |
dc.subject.other | Diabetes mellitus | pt_BR |
dc.subject.other | Gliclazida | pt_BR |
dc.title | Synthesis and characterization of a molecularly imprinted polymer (MIP) for solid-phase extraction of the antidiabetic gliclazide from human plasma | pt_BR |
dc.type | Artigo de Periódico | pt_BR |
dc.url.externa | https://www.sciencedirect.com/science/article/pii/S0928493120316891 | pt_BR |
Appears in Collections: | Artigo de Periódico |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Synthesis and characterization of a molecularly imprinted polymer (MIP) for solid-phase extraction of the antidiabetic gliclazide from human plasma.pdf | 1.37 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.